申请人:Marion Laboratories, Inc.
公开号:US04843074A1
公开(公告)日:1989-06-27
Novel 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts and their use as antimuscarinic agents having antisecretory activity selective for the gastrointestinal tract are disclosed. The compounds have the formula: ##STR1## wherein: X=H, halogen, lower alkyl, lower alkoxy, hydroxy, and R=morpholinyl, thiomorpholinyl, piperidinyl, 1,4-dioxa-8-azaspiro[4.5]decanyl, 4-(2,6-dimethylmorpholinyl), 4-ketopiperidinyl, 4-hydroxypiperidinyl, 4-substituted piperazinyl (wherein the substituent is lower alkyl, hydroxyalkyl, acetoxyalkyl, or acyl). Also disclosed are pharmaceutical compositions for treatment of irritable bowel syndrome and methods for using such compounds.
揭示了1-azabicyclo[2.2.2]辛烷-3-基2-芳基-3-氮杂环-2-羟基丙酸酯及其季铵盐,以及它们作为选择性针对胃肠道具有抗分泌活性的抗胆碱药物的用途。这些化合物具有以下结构式:##STR1##其中:X=H、卤素、较低的烷基、较低的烷氧基、羟基,R=吗啉基、硫代吗啉基、哌啶基、1,4-二氧-8-氮杂螺[4.5]癸基、4-(2,6-二甲基吗啉基)、4-酮哌啶基、4-羟基哌啶基、4-取代哌嗪基(其中取代基为较低的烷基、羟基烷基、乙酰氧基烷基或酰基)。还揭示了用于治疗肠易激综合征的药物组合物以及使用这些化合物的方法。